Stronger Immune System Cuts Prostate Risk 14%
Stronger Immune System Cuts Prostate Risk 14%
Stronger Immune System Cuts Prostate Risk 14%
Key points
اہم نکات
मुख्य बातें
- Men with higher levels of a key immune protein had a 14% lower risk of prostate cancer, Oxford researchers have found, in the largest study of its kind.
- The team tracked 368 immune and inflammation proteins in blood samples, comparing 1,434 men who later developed prostate cancer with 1,434 who did not, plus 21,481 men in the UK Biobank.
- Higher levels of the protein interleukin-15 were also linked to a 26% lower risk of advanced prostate cancer, with the strongest signals appearing more than seven years before diagnosis.
- Men with higher levels of a key immune protein had a 14% lower risk of prostate cancer, Oxford researchers have found, in the largest study of its kind.
- The team tracked 368 immune and inflammation proteins in blood samples, comparing 1,434 men who later developed prostate cancer with 1,434 who did not, plus 21,481 men in the UK Biobank.
- Higher levels of the protein interleukin-15 were also linked to a 26% lower risk of advanced prostate cancer, with the strongest signals appearing more than seven years before diagnosis.
- Men with higher levels of a key immune protein had a 14% lower risk of prostate cancer, Oxford researchers have found, in the largest study of its kind.
- The team tracked 368 immune and inflammation proteins in blood samples, comparing 1,434 men who later developed prostate cancer with 1,434 who did not, plus 21,481 men in the UK Biobank.
- Higher levels of the protein interleukin-15 were also linked to a 26% lower risk of advanced prostate cancer, with the strongest signals appearing more than seven years before diagnosis.
Men with higher levels of a key immune protein had a 14% lower risk of prostate cancer, Oxford researchers have found, in the largest study of its kind. The team tracked 368 immune and inflammation proteins in blood samples, comparing 1,434 men who later developed prostate cancer with 1,434 who did not, plus 21,481 men in the UK Biobank. Higher levels of the protein interleukin-15 were also linked to a 26% lower risk of advanced prostate cancer, with the strongest signals appearing more than seven years before diagnosis.
Men with higher levels of a key immune protein had a 14% lower risk of prostate cancer, Oxford researchers have found, in the largest study of its kind. The team tracked 368 immune and inflammation proteins in blood samples, comparing 1,434 men who later developed prostate cancer with 1,434 who did not, plus 21,481 men in the UK Biobank. Higher levels of the protein interleukin-15 were also linked to a 26% lower risk of advanced prostate cancer, with the strongest signals appearing more than seven years before diagnosis.
Men with higher levels of a key immune protein had a 14% lower risk of prostate cancer, Oxford researchers have found, in the largest study of its kind. The team tracked 368 immune and inflammation proteins in blood samples, comparing 1,434 men who later developed prostate cancer with 1,434 who did not, plus 21,481 men in the UK Biobank. Higher levels of the protein interleukin-15 were also linked to a 26% lower risk of advanced prostate cancer, with the strongest signals appearing more than seven years before diagnosis.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।